Factors influencing risk reduction surgery among BRCA mutation carriers: A qualitative analysis.

Authors

null

Rachael Brandt

Lankenau Medical Center

Rachael Brandt , Cristina Polinsky , Jessica Katz , Minal Dhamankar , Rosemarie Tucci , Jennifer Sabol , Terri McHugh

Organizations

Lankenau Medical Center, Main Line Surgeons, Lankenau Hospital

Research Funding

No funding sources reported
Background: Women known to carry deleterious mutations in BRCA1 and BRCA2 have a substantially increased lifetime risk to develop breast and ovarian cancer. Current risk management options include increased surveillance, chemoprevention and risk reducing surgery. Several studies have quantitatively evaluated the reasoning of high risk women for electing surgical intervention, noting mutation carrier status as a significant, but not sole rationale for this decision. The decision for surgery has also been associated with family cancer history, anxiety, demographics, healthcare setting and prior counseling. More insights regarding factors influencing women’s choice for risk reduction are needed. Methods: To further assess factors influencing the decision to have risk reduction surgery among women in a community hospital system, 129 BRCA mutation carriers in a community-based genetic counseling program were invited to participate in a qualitative study using questionnaires. A thematic analysis was performed by two independent reviewers on open dialogue responses. Results: Of the 59 respondents, 54 completed the question specifically addressing factors regarding the decision on surgery. Of them, 32 opted for mastectomy, salpingo-oophorectomy or both and 22 opted against surgical risk reduction. Themes emerging in support of surgery included: vicarious experience attributable to a strong family history of cancer; desire for control over risk through surgical intervention; high risk perception; co-morbidities; desire for living, regarding longevity and for loved ones; fear of cancer; and skepticism related to cancer detection methods. For women opting against surgery, themes included: co-morbidities; age (too old/young); incomplete childbearing; logistics (scheduling, finances); lack of disease; and skepticism in effectiveness of surgery. Conclusions: While various factors have been studied regarding the association with or probability of women’s decisions for risk reduction surgery, a deeper comprehension of women’s reasoning can be attained through qualitative analysis. This understanding may enhance health care providers’ ability to counsel women regarding this choice.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2012 Breast Cancer Symposium

Session Type

Poster Session

Session Title

General Poster Session A

Track

Risk Assessment, Prevention, Detection, and Screening

Sub Track

High Risk

Citation

J Clin Oncol 30, 2012 (suppl 27; abstr 53)

DOI

10.1200/jco.2012.30.27_suppl.53

Abstract #

53

Poster Bd #

D14

Abstract Disclosures

Similar Abstracts

First Author: Rebecca A. Previs

Abstract

2022 ASCO Annual Meeting

Hysterectomy as a risk-reducing procedure in BRCA1 and BRCA2 women.

First Author: Ana Teresa Pina

Abstract

2018 Gastrointestinal Cancers Symposium

BRCA1 and BRCA2 gene mutations and colorectal cancer risk: Systematic review and meta-analysis.

First Author: Mok Oh